A detailed history of Black Rock Inc. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,344,605 shares of BMEA stock, worth $9.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,344,605
Previous 1,973,500 18.8%
Holding current value
$9.4 Million
Previous $29.5 Million 64.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.14 - $15.3 $1.54 Million - $5.68 Million
371,105 Added 18.8%
2,344,605 $10.6 Million
Q1 2024

May 10, 2024

SELL
$13.92 - $19.5 $2.55 Million - $3.57 Million
-182,842 Reduced 8.48%
1,973,500 $29.5 Million
Q4 2023

Feb 13, 2024

BUY
$8.37 - $19.8 $736,760 - $1.74 Million
88,024 Added 4.26%
2,156,342 $31.3 Million
Q3 2023

Nov 13, 2023

BUY
$13.44 - $23.02 $1.44 Million - $2.47 Million
107,129 Added 5.46%
2,068,318 $28.5 Million
Q2 2023

Aug 11, 2023

BUY
$21.66 - $41.8 $21.2 Million - $41 Million
980,355 Added 99.95%
1,961,189 $43 Million
Q1 2023

May 12, 2023

BUY
$6.8 - $32.35 $2.94 Million - $14 Million
432,096 Added 78.74%
980,834 $30.4 Million
Q4 2022

Feb 13, 2023

SELL
$6.3 - $11.6 $710,318 - $1.31 Million
-112,749 Reduced 17.04%
548,738 $4.63 Million
Q3 2022

Nov 14, 2022

SELL
$9.51 - $13.61 $1.95 Million - $2.8 Million
-205,510 Reduced 23.7%
661,487 $6.47 Million
Q2 2022

Aug 12, 2022

SELL
$3.0 - $12.03 $2.52 Million - $10.1 Million
-838,445 Reduced 49.16%
866,997 $10.4 Million
Q1 2022

May 12, 2022

BUY
$4.39 - $9.03 $143,263 - $294,685
32,634 Added 1.95%
1,705,442 $7.61 Million
Q4 2021

Feb 10, 2022

BUY
$7.22 - $12.72 $5.29 Million - $9.32 Million
733,067 Added 78.01%
1,672,808 $12.5 Million
Q3 2021

Nov 09, 2021

SELL
$10.0 - $15.99 $1.62 Million - $2.59 Million
-161,948 Reduced 14.7%
939,741 $11.2 Million
Q2 2021

Aug 11, 2021

BUY
$13.65 - $20.93 $15 Million - $23.1 Million
1,101,689 New
1,101,689 $17.2 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $117M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.